ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Hydrochloric Acid → 2-[3-Iodo-4-(1,3-oxazol-5-yl)phenyl]-1,3-benzothiazol-6-ol

HRID 910238
印刷

反応式

HRID 910238 の反応式
NC1SC2C=C(OC)C=CC=2N=1.[OH-].[K+].BrC1C=C(C2SC3C=C(OC)C=CC=3N=2)C=CC=1C1OC=NC=1.[I:38][C:39]1[CH:44]=[C:43]([C:45]2[S:46][C:47]3[CH:53]=[C:52]([O:54]C)[CH:51]=[CH:50][C:48]=3[N:49]=2)[CH:42]=[CH:41][C:40]=1[C:56]1[O:60][CH:59]=[N:58][CH:57]=1.B(Br)(Br)Br.Cl>O.ClCCl.C(O)(=O)C>[I:38][C:39]1[CH:44]=[C:43]([C:45]2[S:46][C:47]3[CH:53]=[C:52]([OH:54])[CH:51]=[CH:50][C:48]=3[N:49]=2)[CH:42]=[CH:41][C:40]=1[C:56]1[O:60][CH:59]=[N:58][CH:57]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

10

反応物 6

HCID 313Hydrochloric AcidHCID 14797Potassium HydroxideHCID 156302-Amino-6-methoxybenzothiazoleHCID 25134Boron tribromideHCID 674042425-[2-Iodo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole2 回HCID 674057305-[2-Bromo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole2 回

生成物

1
HCID 674039232-[3-Iodo-4-(1,3-oxazol-5-yl)phenyl]-1,3-benzothiazol-6-ol

試薬・触媒・溶媒 3

HCID 176Acetic Acid溶媒HCID 962Water溶媒HCID 6344Dichloromethane溶媒

実験手順

2-Amino-6-methoxybenzothiazole (3.0 g) was added to a solution (100 mL) of potassium hydroxide (21.9 g) in water, followed by refluxing under heating for 15 hours. The mixture was neutralized with 5N aqueous acetic acid solution, and the precipitated crystals were recovered through filtration. The procedure of Referential Example 22 was repeated, except that the thus-recovered 2-amino-5-methoxy-1-benzenethiol (185 mg) and 3-bromo-4-(1,3-oxazol-5-yl)benzaldehyde (300 mg), which had been produced in Referential Example 26, were used, to thereby yield 5-[2-bromo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole (450 mg). Subsequently, The procedure of Referential Example 12 was repeated, except that 5-[2-bromo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole (450 mg) was used, to thereby yield 5-[4-(6-methoxy-1,3-benzothiazol-2-yl)-2-(1,1,1-tributylstannyl)phenyl]-1,3-oxazole (15 mg). Thereafter, the procedure of Example 12 was repeated, except that 5-[4-(6-methoxy-1,3-benzothiazol-2-yl)-2-(1,1,1-tributylstannyl)phenyl]-1,3-oxazole (15 mg) was used, to thereby yield 5-[2-iodo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole. Under a stream of argon, boron tribromide (200 μL, 1M dichloromethane solution) was added dropwise to a solution (30 mL) of 5-[2-iodo-4-(6-methoxy-1,3-benzothiazol-2-yl)phenyl]-1,3-oxazole (20 mg) in dichloromethane, and the mixture was stirred at room temperature for 23 hours. 1N Aqueous hydrochloric acid solution was added to the reaction mixture, followed by extraction with ethyl acetate. The solvent was evaporated, and the residue was purified through silica gel column chromatography (n-hexane:ethyl acetate=1:1), to thereby yield the title compound (10 mg).

後処理

  1. temperatureby refluxing
  2. temperatureunder heating for 15 hours
  3. filtrationthe precipitated crystals were recovered through filtration
  4. customhad been produced in Referential Example 26
  5. extractionfollowed by extraction with ethyl acetate
  6. customThe solvent was evaporated
  7. customthe residue was purified through silica gel column chromatography (n-hexane:ethyl acetate=1:1)

出典と根拠

ORDレコード
ord-749391b8ee554b64a7a59308da093184
出典データセット
uspto-grants-2011_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08022075B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート